News from lipid therapeutics A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Sep 16, 2015, 08:00 ET Lipid Therapeutics Licenses Rights to its Novel Therapy for Ulcerative Colitis to Nestlé Health Science

Nestlé Health Science to develop and commercialise LT-02 worldwide, except in Europe and Australia Lipid Therapeutics today announces that it has...


Oct 29, 2014, 06:24 ET Lipid Therapeutics' European Partner Dr. Falk Pharma GmbH Enrolls First Patients Into Pivotal Phase III Trial With LT-02, a Novel Therapy for Ulcerative Colitis (UC)

Positive FDA feedback on the protocol for the US Phase III trial with LT-02, a key element of the product's global development program Lipid...


Apr 10, 2013, 03:00 ET Lipid Therapeutics Successfully Files a US IND for LT-02, a Novel Barrier Function Therapy for Ulcerative Colitis

IND paves the way for the US element of a global Phase III development program with LT-02 in conjunction with European licensee Dr. Falk Pharma GmbH, ...


Mar 08, 2012, 03:00 ET Lipid Therapeutics Licenses European Rights to its Lead Product, LT-02, to Co-development Partner Dr. Falk Pharma GmbH

Dr. Falk Pharma GmbH to initiate Phase III trial Dr. Falk Pharma GmbH and Lipid Therapeutics, a biotechnology company focused on novel treatments for ...


Jun 22, 2011, 03:00 ET Lipid Therapeutics Announces Positive Topline Phase IIb Results With LT-02 in Patients With Ulcerative Colitis

- Primary Endpoint Met Lipid Therapeutics, a biotechnology company focused on novel treatments for inflammatory bowel disease, today announced...